PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests an experimental drug called M9140 in people with advanced solid tumors (gastric, lung, or pancreatic cancer) that have a specific protein (CEACAM5). The drug is designed to deliver a toxin directly to cancer cells. About 250 adults will receive the drug alone or …
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Phase: PHASE1, PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New drug duo takes on tough pancreatic cancer
Disease control OngoingThis early-phase trial is testing whether two drugs, HRS-4642 and nimotuzumab, can safely shrink tumors in people with recurrent or metastatic pancreatic ductal adenocarcinoma. About 20 patients will receive the combination to find the best dose and see how well it works. The goa…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Phase: PHASE1, PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New antibody combo tested against hard-to-treat cancers
Disease control OngoingThis early-phase trial tests an experimental antibody called GEN1042, given alone or with the cancer drug pembrolizumab (and sometimes chemotherapy), in people with advanced solid tumors like lung, colon, melanoma, head and neck, or pancreatic cancer. The main goals are to check …
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
Pancreatic cancer study tracks early return after surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches 500 adults with pancreatic cancer who had surgery to remove their tumor. The goal is to see how often the cancer comes back within the first year, where it shows up, and how doctors find it. No new treatments are tested—just careful tracking during normal check…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Sponsor: Azienda Ospedaliera di Padova • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:07 UTC
-
New models aim to forecast pancreatic cancer outcomes
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to create computer models that predict how long patients with advanced pancreatic cancer might live and how well they respond to chemotherapy. Researchers will use medical images, tissue samples, and genetic data from 100 patients. The goal is to help doctors make…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC